WO2011053242A1 - A spacer and a method of using the same - Google Patents
A spacer and a method of using the same Download PDFInfo
- Publication number
- WO2011053242A1 WO2011053242A1 PCT/SG2009/000396 SG2009000396W WO2011053242A1 WO 2011053242 A1 WO2011053242 A1 WO 2011053242A1 SG 2009000396 W SG2009000396 W SG 2009000396W WO 2011053242 A1 WO2011053242 A1 WO 2011053242A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tube
- spacer
- stomach
- opening
- sphere
- Prior art date
Links
- 125000006850 spacer group Chemical group 0.000 title claims abstract description 90
- 238000000034 method Methods 0.000 title claims abstract description 13
- 210000002784 stomach Anatomy 0.000 claims abstract description 65
- 239000000463 material Substances 0.000 claims description 17
- 210000003815 abdominal wall Anatomy 0.000 claims description 12
- 229920002988 biodegradable polymer Polymers 0.000 claims description 12
- 239000004621 biodegradable polymer Substances 0.000 claims description 12
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 17
- 235000013305 food Nutrition 0.000 abstract description 17
- 229940079593 drug Drugs 0.000 abstract description 6
- 210000003200 peritoneal cavity Anatomy 0.000 description 11
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229920000117 poly(dioxanone) Polymers 0.000 description 2
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 2
- 101100021395 Arabidopsis thaliana LIP1 gene Proteins 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- -1 poly trimethylene carbonate Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0015—Gastrostomy feeding-tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0026—Parts, details or accessories for feeding-tubes
- A61J15/003—Means for fixing the tube inside the body, e.g. balloons, retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0026—Parts, details or accessories for feeding-tubes
- A61J15/003—Means for fixing the tube inside the body, e.g. balloons, retaining means
- A61J15/0046—Expandable retainers inside body lumens of the enteral tract, e.g. fixing by radially contacting a lumen wall
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0026—Parts, details or accessories for feeding-tubes
- A61J15/0053—Means for fixing the tube outside of the body, e.g. by a special shape, by fixing it to the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2200/00—General characteristics or adaptations
- A61J2200/60—General characteristics or adaptations biodegradable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0133—Tip steering devices
- A61M2025/0163—Looped catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M2025/0213—Holding devices, e.g. on the body where the catheter is attached by means specifically adapted to a part of the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
Abstract
The invention relates to a spacer (6) and a method of using the same. The spacer (6) retains a physical length of a gastrostomy tube (2) having an opening within the stomach of an individual. The opening (4) is designed to allow food and medicines to enter the stomach. The spacer (6) is not permanently affixed to the tube (2) thereby the tube (2) can be moved independently of the spacer (6) at the time the tube (2) is due to be changed and as such can be changed percutaneously by anyone including caregivers.
Description
A Spacer and a method of using the same
Field of the invention
The present invention is designed for use with a new generation gastrostomy tube and generally relates to a means of ensuring the feeding outlet remains in place within the stomach.
Background Information
Diseases sometimes leave their victims unable to feed orally. For these patients, a tube may be used to convey liquid food to the stomach.
In those cases where the tube passes through a nostril, down the oesophagus, and into the stomach, it is known as a naso-gastric tube. When the tube passes to the stomach through the anterior abdominal wall of the patient, it is known as a gastrostomy tube. The gastrostomy tube is the preferred method when feeding via a tube is required for a long time by the patient.
There are a few methods available to insert the gastrostomy tube into the patient. Of these, the pull-through percutaneous endoscopic gastrostomy (pull-through PEG) technique is the most-widely used over the past 30 years.
A new generation gastrostomy tube is described in WO2009/048422. This tube is looped through two stomas in the patient's abdomen ensuring the gastrostomy tube bypasses the nose; is capable of insertion under local anaesthetic; is not easily pulled out of position; and is simple and easy to change regularly by anyone. To change to a new tube, all that is required is that the new tube be connected to the old tube with a connector, then the new tube is pulled through into the same position as the old tube, and the connector and the old tube are removed with very little trauma to the patient.
The new generation gastrostomy tube 2 is illustrated in figure 1. The tube 2 has an opening 4 designed to allow food and medicines to enter the stomach. This opening 4 should remain within the stomach. One problem with this new
generation gastrostomy tube 2 is that as the stomach contracts and moves there is a risk that the opening 4 designed to allow food and medicines to enter the stomach may slip though the aperture in the stomach and be positioned between the abdominal wall and the stomach wall within the peritoneal cavity as depicted in figures 2 and 3. This may lead to serious complications during feeding and may lead to the death of the patient.
One way to overcome this problem is to stitch the stomach wall to the abdominal wall on the outside of the two stomas at A and B in figure 1.
However, this will be uncomfortable for the patient providing a source of further pain and aggravation and increasing the risk of infection and bleeding at the two stitch sites.
Summary of the Invention
It is an object of this invention to provide a means of ensuring the opening of the new generation gastrostomy tube remains in place within the stomach and may ameliorate some or all of the problems of prior art.
In accordance with a first aspect of the present invention there is provided a device for ensuring an opening of a gastrostomy tube remains in place within a stomach comprising a spacer not permanently affixed to the tube whereby the spacer is adapted to allow the tube to be changed percutaneously.
Such a device may be advantageous in that the spacer may trap the opening within the stomach such that food or medicine may only be released through the opening into the stomach and food or medicine may be prevented from escaping from the opening into the peritoneal cavity.
In a first embodiment the spacer may comprise a coil spring defining an aperture through the center of the coil such that the tube can move
independently of the spacer when in use.
The device of the first embodiment may further include an individual coil of the spacer being in an extended configuration and being spaced apart from an adjacent coil.
The device of the first embodiment may further comprise flexible coils of the spacer.
Preferably the spacer of the first embodiment may be a Shore A Hardness of at least less than 100.
Preferably the spacer of the first embodiment may further comprise a flange at an end of the coil spring.
In a second embodiment the spacer may comprise a hollow sphere with an aperture formed through the sphere allowing a tube to pass through the aperture formed through the sphere.
Preferably the sphere of the second embodiment may have perforations on the surface of the sphere.
The device of the first or second embodiment may be made of polyurethane, silicone, or a biodegradable material such as a biodegradable polymer that will absorb within a time suitable for a stoma to mature.
In a third embodiment the spacer may comprise a biodegradable polymer that may be locked over the tube such that two sections of the tube loop through the spacer. Alternatively the spacer of the third embodiment may be anchored to the tube prior to use.
Preferably the biodegradable polymer of the invention may be absorbed within 3 to 6 months. More preferably the biodegradable polymer is a d-l copolymer blend of polylactide (DLPLA).
In accordance with another aspect of the present invention there is provided a method of ensuring an opening of a gastrostomy tube remains in place within a stomach comprising the steps of: placing a spacer over the tube; placing the tube with the spacer endoscopically into the stomach; forcing a first end of the tube through the stomach and abdominal wall at a first location; and forcing a second end of the tube through the stomach and abdominal wall at a second
location, whereby the spacer retains a physical length of the tube having the opening within the stomach.
Brief Description of the Drawings
The invention will be better understood by reference to the following drawings in which:
Figure 1 is an illustration of the prior art new generation gastrostomy tube in use.
Figure 2 is an illustration of the prior art new generation gastrostomy tube in use depicting the opening that is designed to deliver food and medicines to the stomach in the peritoneal cavity.
Figure 3 is an illustration of the prior art new generation gastrostomy tube in use depicting the opening that is designed to deliver food and medicines to the stomach in the peritoneal cavity.
Figure 4 is an illustration of the device according to the first embodiment of the invention in use.
Figure 5 is an illustration of the device according to the first embodiment of the invention.
Figure 6 is an illustration of the device according to the second embodiment of the invention in use.
Figure 7 is an illustration of the device according to the second embodiment of the invention.
Figure 8 is an illustration of the device according to the third embodiment of the invention in use.
Figure 9 is an illustration of the device according to the third embodiment of the invention.
Figure 10 is an illustration of the device according to the third embodiment of the invention in use.
Detailed description of the preferred embodiments of the Invention
The invention occupies space within the stomach and retains the physical length of the tube and the opening 4, designed to allow food and medicines to enter the stomach, to remain within the stomach. The spacer is not permanently affixed to the tube. Thereby the tube can be moved
independently of the spacer at the time the tube is due to be changed and as such can be changed percutaneously by anyone including caregivers.
The invention is designed for use with a new generation enteral feeding tube or new generation gastrostomy tube.
In accordance with the invention a device is provided for ensuring the opening of the new generation gastrostomy tube remains in place within the stomach comprising a spacer that is not permanently affixed to the tube. The spacer defines an aperture adapted to allow a tube to pass through the aperture whereby the spacer forms a sheath or collar adapted to slide over and along the tube. The spacer has dimensions larger than each of the diameter of the two stomas in the stomach through which the new generation gastrostomy tube passes thereby trapping the device to remain within the stomach such that it cannot escape through the stomas.
The device of the invention will allow a wide range of tube sizes to pass through the aperture, provided the diameter of the spacer aperture is larger than the size of the tube the spacer can be used with that tube. For example a device designed to fit a 20 Fr tube can also be used with a 15 Fr sized tube or a 14 Fr sized tube, and in fact any tube size smaller than 20 Fr. Similarly a device designed to fit a 24 Fr tube can also be used with a 20 Fr sized tube or a 15 Fr or 14 Fr sized tube in fact any tube size smaller than 24 Fr.
Referring to figures 4 and 5 in accordance with a first embodiment of a device for ensuring the opening of the new generation gastrostomy tube remains in place within the stomach comprises a spacer shaped like a helical coil spring 6a defining the aperture through the center of the coil such that the tube 2 can move independently and freely of the spacer 6a. In its resting state, the individual coil or loop is in an extended configuration and is spaced apart from its neighboring coil or loop. At Shore A Hardness of about 50 to 75 units or at least less than 100, the spacer 6a of the first embodiment is flexible and floppy. The spacer may further have flanges at either end of the coil. As the ends of the coil will abut against the gastric mucosa when in use, flanges may help to distribute pressure over a wider surface area of the gastric mucosa and reduce the risk of any trauma to the stomach lining.
The first embodiment may be made of polyurethane, or silicone, or a biodegradable material or any suitable material which can tolerate the acidic environment of the stomach. Preferably any biodegradable material chosen will have a suitable rate of degradation to dissolve only after the stomas have fully matured and there is no risk of the midsection of the tube 2 where the opening 4 is located escaping into the peritoneal cavity. It is generally accepted by doctors that the stoma will mature in 4- 6 weeks. Hence, preferably the biodegradable material chosen will absorb after 6 weeks or more.
To deploy the first embodiment the spacer 6a is slid over the tube 2 whereby the coil 6a forms a loose outer porous sheath over the tube. Then the tube 2, with the spacer 6a in place, is inserted into position within the stomach using the pull through method of percutaneous endoscopic gasrostomy (PEG). A first end 3 of the tube 2 is forced through the stomach wall and through the abdomen forming a first stoma. A second end 5 of the tube 2 is forced through the stomach wall and through the abdomen forming a second stoma. The spacing between the coils of the spring gives an indication of the tension with which the first 3 and second 5 end of the tube are tied or locked together. When in position within the stomach a caregiver may introduce fluids into the tube to flow through the tube 2 and exit from the opening 4, and pass between
the coil springs into the stomach. The spacer 6a ensures the opening 4 remains within the stomach such that food or medicine is only released through the opening 4 into the stomach and no food or medicine escapes from the opening 4 into the peritoneal cavity.
When the tube is changed it is done percutaneously not requiring endoscopy and as such can be changed by anyone including a caregiver. The old tube is untied or unlocked. A new tube is connected to the first end 3 or the second end 5 of the old tube. The old tube is pulled out by pulling the free end of the old tube, not connected to the new tube, thereby automatically guiding the new tube into position. The old tube is then detached and the first 3 and second 5 end of the new tube are tied or locked together. The old and new tubes 2 are able to slide through the aperture formed in the spacer 6a as the coils forms a loose sheath over the tube such that the spacer 6a does not interfere with changing the tube 2.
Referring to figure 6 and 7 in accordance with a second embodiment of a device of the invention, the device comprises a spacer in the shape of a sphere 6b. Preferably the sphere 6b is hollow with a plurality of holes or perforations 7 formed on the surface of the sphere. An aperture is formed through the sphere 6b by the holes 7 adapted to allow a tube 2 to pass through the aperture. Preferably more than one aperture is provided.
The second embodiment may be made of polyurethane, or silicone, or a biodegradable material or any suitable material which can tolerate the acidic environment of the stomach. Preferably any biodegradable material chosen will have a suitable rate of degradation to dissolve only after the stomas have fully matured and there is no risk of the midsection of the tube 2 where the opening 4 is located escaping into the peritoneal cavity. It is generally accepted by doctors that the stoma will mature in 4- 6 weeks. Hence, preferably the biodegradable material chosen will absorb after 6 weeks or more.
When in use more than one sphere 6b may be strung over the tube 2.
Preferably a plurality of spheres are used forming a chain or series. Typically,
the number of spheres 6b required is a matter of clinical judgement on the part of the doctor, taking the habitus of the patient, the distance between the stomas, and other factors into consideration. The tube 2 and the spacer 6b are initially inserted using the PEG method described above. As the spheres 6b are not affixed to the tube 2 the tube may be changed percutaneously as described above. The old and new tubes 2 are able to slide through the aperture formed in the spheres 6b as they are not affixed to the tube 2 such that the spacer 6b does not interfere with changing the tube 2. The spacer 6b or plurality of spacers 6b ensures the opening 4 remains within the stomach such that food or medicine is only released through the opening 4 into the stomach and no food or medicine escapes from the opening 4 into the peritoneal cavity.
Referring to figures 8, 9 and 10 in accordance with a third embodiment of a device of the invention, the device comprises a spacer manufactured of biodegradable material 6c.
Preferably one spacer 6c is used as depicted in figure 10. The one spacer 6c forms a lock over the tube 2 as the tube 2 is looped twice through the spacer 6c such that when the tube and the one spacer are initially put into the stomach via the PEG method described above the spacer 6c ensures the opening 4 remains within the stomach such that food or medicine is only released through the opening 4 into the stomach and no food or medicine escapes from the opening 4 into the peritoneal cavity. Then as the
stomas mature by the formation of a fibrous track securing the stomach wall to the abdominal wall the spacer 6c is absorbed into the stomach and the spacer 6c no longer holds the tube 2 in the twice-looped configuration. When the stomas have matured, the tube 2 cannot migrate into the peritoneal cavity. Hence, the spacer 6c is designed to biodegrade after the stomas have matured at about 6 weeks. When the polymer is degraded, the tube can be changed without interference.
Similarly in figure 9, where at least two spacers 6c manufactured of biodegradable material are used the opening 4 adapted to allow food and medicine to enter the stomach is positioned between the two spacers 6c, and
cannot escape from the stomach. The two spacers are not permanently affixed to the tube 2 but are anchored to the segment of the tube in such a way that the spacers 6c are temporarily affixed to the tube but as they are made of biodegradable material the spacers 6c absorb over time allowing the tube to be changed percutateously without interference after the stomas have matured.
When in use the tube 2 and the at least two spacers 6c are initially inserted using the PEG method described above. As the spacers 6c biodegrade, when it is time to change the tube 2, the tube 2 may be changed percutaneously as described above. The at least two spacers 6c ensures the opening 4 remains within the stomach such that food or medicine is only released through the opening 4 into the stomach and no food or medicine escapes from the opening 4 into the peritoneal cavity.
Biodegradable material includes both natural and synthetic polymers that will dissolve over time. Such material should also be suitable for medical use. Many biodegradable polymers are prepared from glycolic acid, lactic acid and other ohydroxy acids. Suitable biodegradable material may include poly dioxanone poly trimethylene carbonate, poly e- caprolactone homo polymers and copolymers, polyanhydrides, polyorthoesters, polyphosphazenes or any other suitable biodegradable material known to those skilled in the art.
Biodegradable polymers with a shorter degradation time may include polyglycolide (PGA) or the d-l copolymer blend of polylactide (DLPLA) or poly (dioxanone) (a polyester-ester) (PDS) or poly (lactide-co-glycolide) or any other biodegradable polymer known to absorb within 3 to 6 months.
Biodegradable polymer with a longer biodegradation time may include the I isomer of polylactide (LPLA) or poly (e-caprolactone) or any other
biodegradable polymer known to absorb within 1 to 2 years, or at least more than 6 months.
The matured stoma has a fibrous track that forms between the stomach wall and the abdominal wall, thereby securing the stomach wall to the abdominal wall. In such a circumstance tube migration cannot occur. Hence, the spacer
6c is no longer needed and is allowed to biodegrade when the stomas have matured.
In another embodiment, a combination of the first, second and/or third embodiment may be used. For example a combination of one sphere and 2 coils may be used. Alternatively, a combination of the at least two
biodegradable spacer and a sphere may be employed. Alternatively, a combination of a coil spring and the at least two biodegradable spacer may be employed. Any combination which is deemed by the doctor to be appropriate for the patient may be used.
In surgical operations, tension is an important consideration. Too much tension can diminish blood supply and strangulate the living tissues. The present invention provides endoscopic visual clues to the doctor regarding the tension in the system. In the first embodiment, the spacing between the coils of the spring has a relationship to the degree of tension placed on the system. Similarly for the second embodiment, the hollow feature of the sphere ensures that the deformity of the sphere has a relationship to the degree of tension placed on the system.
The invention can be manufactured using techniques known in the art at relatively low cost.
In the situation a patient has recovered from his illness and the enteral feeding tube is no longer required the tube is removed percutaneously and the spacer is preferentially left in the stomach and allowed to pass
spontaneously through the intestines and out via the anus. Alternatively, the spacer is left to biodegrade or be absorbed. Alternatively, the spacer may be removed endoscopically via the mouth.
Throughout this document, unless otherwise indicated to the contrary, the terms "comprising", "consisting of, and the like, are to be construed as non- exhaustive, or in other words, as meaning "including, but not limited to".
Various embodiments and extra features are envisioned in relation to the present invention. They include:
9 000396
11
• The invention can be modified for use in veterinary surgery.
• The spacer may be made radio-opaque to become visible on X-rays. In
the situation where the tube is radio-translucent and the spacer is
radio-opaque an estimation of the length of tubing within the stomach can be determined by taking an X-Ray.
• The spacer may be made of any size, provided it is larger that the
stomas cut through the stomach wall and abdominal wall. e The spacer may be any shape although preferably with smooth
contours to minimize trauma to the stomach lining.
• The spacer can be used as an intussusceptum to lead a fine bore
feeding tube into the small intestines.
° The spacer may contain one or more sensors able to transmit data on
the use of the system or relating to the patient's health wirelessly to a microprocessor. For example a microprocessor at a nursing control station
Modifications and variations as would be apparent to a skilled addressee are deemed to be within the scope of the present invention.
Claims
1. A device for ensuring an opening of a gastrostomy tube remains in place within a stomach comprising a spacer not permanently affixed to the tube whereby the spacer is adapted to allow the tube to be changed percutaneously.
2. The device of claim 1 wherein the spacer comprises a coil spring defining an aperture through the center of the coil such that the tube can move independently of the spacer when in use.
3. The device of claim 2 wherein an individual coil of the spacer is in an extended configuration and is spaced apart from an adjacent coil.
4. The device of claim 2 or 3 wherein the coils are flexible.
5. The device of claim 4 wherein the spacer is a Shore A Hardness of at least less than 100.
6. The device of any one of claim 2 to 5 wherein the spacer further
comprises a flange at an end of the coil spring.
7. The device of claim 1 wherein the spacer comprises a hollow sphere with an aperture formed through the sphere allowing a tube to pass through the aperture formed through the sphere.
8. The device of claim 7 wherein the surface of the sphere has
perforations.
9. The device of any one of the preceding claims wherein the spacer is made of polyurethane.
10. The device of any one of claims 1 to 8 wherein the spacer is made of silicone.
11. The device of any one of claims 1 to 8 wherein the spacer is made of a biodegradable material polymer that will absorb within a time suitable for a stoma between the stomach wall and the abdominal wall to mature.
12. The device of claim 11 wherein the spacer is anchored to the tube prior to use.
13. The device of claim 1 wherein the spacer comprises a biodegradable polymer locked over the tube such that two sections of the tube loop through the spacer.
1 . The device of any one of claims 11 to 13 wherein the biodegradable polymer is absorbed within 3 to 6 months.
15. The device of claim 14 wherein the biodegradable polymer is a d-l
copolymer blend of polylactide (DLPLA).
16. A method of ensuring an opening of a gastrostomy tube remains in
place within a stomach comprising the steps of: a. placing a spacer over the tube; b. placing the tube with the spacer endoscopically into the stomach; c. forcing a first end of the tube through the stomach and
abdominal wall at a first location; and d. forcing a second end of the tube through the stomach and
abdominal wall at a second location, whereby the spacer retains a physical length of the tube having the opening within the stomach.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/SG2009/000396 WO2011053242A1 (en) | 2009-10-29 | 2009-10-29 | A spacer and a method of using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/SG2009/000396 WO2011053242A1 (en) | 2009-10-29 | 2009-10-29 | A spacer and a method of using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011053242A1 true WO2011053242A1 (en) | 2011-05-05 |
Family
ID=43922352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SG2009/000396 WO2011053242A1 (en) | 2009-10-29 | 2009-10-29 | A spacer and a method of using the same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011053242A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013070812A (en) * | 2011-09-27 | 2013-04-22 | Nihon Covidien Kk | Fistula catheter |
JP2014002184A (en) * | 2012-06-15 | 2014-01-09 | Sakamoto Moderu:Kk | Injection simulator and method for exchanging imitated blood vessel |
US9211234B2 (en) | 2010-09-27 | 2015-12-15 | Avent, Inc. | Configurable percutaneous endoscopic gastrostomy tube |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4834725A (en) * | 1986-03-27 | 1989-05-30 | Pfrimmer-Viggo Gmbh & Co. | Catheter for percutaneous gastrostomy |
WO1996036378A1 (en) * | 1995-05-15 | 1996-11-21 | Wilson-Cook Medical, Inc. | Gastrostomy feeding ports with positively sealing entrance valves |
US20010044605A1 (en) * | 1998-07-02 | 2001-11-22 | Srinivas Nishtala | Low profile retention system |
US20010053890A1 (en) * | 1996-06-18 | 2001-12-20 | Osborne Thomas A. | Indwelling catheter |
WO2007123630A1 (en) * | 2006-03-27 | 2007-11-01 | Boston Scientific Scimed, Inc. | Catheter assembly including anchor device made from resilient members |
WO2009048422A1 (en) * | 2007-10-11 | 2009-04-16 | Ah San Pang | A device for tube feeding |
-
2009
- 2009-10-29 WO PCT/SG2009/000396 patent/WO2011053242A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4834725A (en) * | 1986-03-27 | 1989-05-30 | Pfrimmer-Viggo Gmbh & Co. | Catheter for percutaneous gastrostomy |
WO1996036378A1 (en) * | 1995-05-15 | 1996-11-21 | Wilson-Cook Medical, Inc. | Gastrostomy feeding ports with positively sealing entrance valves |
US20010053890A1 (en) * | 1996-06-18 | 2001-12-20 | Osborne Thomas A. | Indwelling catheter |
US20010044605A1 (en) * | 1998-07-02 | 2001-11-22 | Srinivas Nishtala | Low profile retention system |
WO2007123630A1 (en) * | 2006-03-27 | 2007-11-01 | Boston Scientific Scimed, Inc. | Catheter assembly including anchor device made from resilient members |
WO2009048422A1 (en) * | 2007-10-11 | 2009-04-16 | Ah San Pang | A device for tube feeding |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9211234B2 (en) | 2010-09-27 | 2015-12-15 | Avent, Inc. | Configurable percutaneous endoscopic gastrostomy tube |
JP2013070812A (en) * | 2011-09-27 | 2013-04-22 | Nihon Covidien Kk | Fistula catheter |
JP2014002184A (en) * | 2012-06-15 | 2014-01-09 | Sakamoto Moderu:Kk | Injection simulator and method for exchanging imitated blood vessel |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Patrick et al. | Endoscopic nasogastric-jejunal feeding tube placement in critically ill patients | |
Shin et al. | Updates on percutaneous radiologic gastrostomy/gastrojejunostomy and jejunostomy | |
EP3123945B1 (en) | Medical instrument | |
JP2011512955A (en) | Nutrition tube | |
WO2011053242A1 (en) | A spacer and a method of using the same | |
US20180055740A1 (en) | Enteral feeding tube | |
Lord | Enteral access devices | |
DeLegge | Enteral access in home care | |
CA2811418A1 (en) | Anti-migration trans-gastric jejunal feeding tube | |
McClave | Techniques in enteral access | |
Vanek | Ins and outs of enteral access. Part 1: short‐term enteral access | |
Wills et al. | Percutaneous gastrostomy. | |
Elliott et al. | PEG—is the E necessary? A comparison of percutaneous and endoscopic gastrostomy | |
Gauderer et al. | Percutaneous endoscopic gastrostomy in children: the technique in detail | |
King et al. | Retrograde percutaneous gastrostomy: a prospective study in 57 children | |
EP2502612A1 (en) | Medical catheter, applications for tubefeeding and method of manufacture | |
Nagle et al. | Laparoscopic gastrostomy and jejunostomy | |
WO2016205701A1 (en) | Enteral fast access tract platform system | |
Yeung et al. | Percutaneous radiologic gastrostomy | |
Panait et al. | Endoscopic approaches to enteral nutrition | |
Eirmann | Esophagostomy feeding tubes in dogs and cats | |
Kirby et al. | Enternal nutrition: the challenge of access | |
Nelson et al. | Using and Troubleshooting Enteral Feeding Devices | |
Berazaluce et al. | Gastrostomy | |
MacGowan | Celestin tube disruption |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09850939 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09850939 Country of ref document: EP Kind code of ref document: A1 |